newsfilter
← Latest News
Business Wire·

Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds

– Provides access to large catalog of compounds complementary to Company's preclinical assets – – Strengthens drug discovery and development platform to build future potential novel drug candidates – – Supports broad intellectual propert